Clinical Trial

BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study is being done to see if the addition of a targeted form of radiation to standard conditioning regimen will increase the amount of cancer cells that are killed off in the bone marrow and reduce the chances that your disease may return. This description is called Intensity Modulated Total Marrow Irradiation (IM-TMI).
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2019-12-03; most recent amendment 2026-03-31.
Trial Details
NCT Number NCT04187105
Lead Sponsor University of Illinois at Chicago
Conditions Acute Leukemia, MDS
Enrollment 27 participants
Start Date 2020-01-27
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-06